MGCD-265 analog
CAS: 875337-44-3
Ref. TM-T6351
| 2mg | 35.00 € | ||
| 5mg | 51.00 € | ||
| 10mg | 82.00 € | ||
| 25mg | 159.00 € | ||
| 50mg | 246.00 € | ||
| 100mg | To inquire | ||
| 1mL*10mM (DMSO) | 60.00 € |
Estimated delivery in United States, on Monday 25 Nov 2024
Product Information
Name:
MGCD-265 analog
Synonyms:
- MGCD-265
- Glesatinib analog
- Mgcd-265
Description:
Glesatinib, an oral tyrosine kinase inhibitor, targets c-Met and VEGFR2 with IC50s of 29 nM and 10 nM, may treat cancer.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
517.6
Formula:
C26H20FN5O2S2
Purity:
98.06% - 98.68%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T6351 MGCD-265 analog
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
